Surgery for oligometastasis of pancreatic cancer

Fengchun Lu; Katherine E. Poruk; Matthew J. Weiss

doi:10.3978/j.issn.1000-9604.2015.05.02

Surgery for oligometastasis of pancreatic cancer

Fengchun Lu, Katherine E. Poruk, Matthew J. Weiss

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable hepatic or pulmonary metastatic disease. Recent advancements in effective systemic therapy for PDAC have led to the selection of certain patients where metastectomy may be potentially indicated. However, the indication for resection of oligometastases in PDAC is not well defined. This review will discuss the current literature on the surgical management of metastatic disease for PDAC with a specific focus on surgical resection for isolated hepatic and pulmonary metastases.

Original language	English (US)
Pages (from-to)	358-367
Number of pages	10
Journal	Chinese Journal of Cancer Research
Volume	27
Issue number	4
DOIs	https://doi.org/10.3978/j.issn.1000-9604.2015.05.02
State	Published - Jan 1 2015

Keywords

Hepatic metastasis
Oligometastasis
Pancreatic cancer (PC)
Pulmonary metastasis
Surgical management

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.3978/j.issn.1000-9604.2015.05.02

Fingerprint Dive into the research topics of 'Surgery for oligometastasis of pancreatic cancer'. Together they form a unique fingerprint.

Cite this

@article{b4c5d97d64c54f029b7e17cf3416292a,

title = "Surgery for oligometastasis of pancreatic cancer",

abstract = "The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable hepatic or pulmonary metastatic disease. Recent advancements in effective systemic therapy for PDAC have led to the selection of certain patients where metastectomy may be potentially indicated. However, the indication for resection of oligometastases in PDAC is not well defined. This review will discuss the current literature on the surgical management of metastatic disease for PDAC with a specific focus on surgical resection for isolated hepatic and pulmonary metastases.",

keywords = "Hepatic metastasis, Oligometastasis, Pancreatic cancer (PC), Pulmonary metastasis, Surgical management",

author = "Fengchun Lu and Poruk, {Katherine E.} and Weiss, {Matthew J.}",

year = "2015",

month = jan,

day = "1",

doi = "10.3978/j.issn.1000-9604.2015.05.02",

language = "English (US)",

volume = "27",

pages = "358--367",

journal = "Chinese Journal of Cancer Research",

issn = "1000-9604",

publisher = "Beijing Institute for Cancer Research",

number = "4",

}

TY - JOUR

T1 - Surgery for oligometastasis of pancreatic cancer

AU - Lu, Fengchun

AU - Poruk, Katherine E.

AU - Weiss, Matthew J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable hepatic or pulmonary metastatic disease. Recent advancements in effective systemic therapy for PDAC have led to the selection of certain patients where metastectomy may be potentially indicated. However, the indication for resection of oligometastases in PDAC is not well defined. This review will discuss the current literature on the surgical management of metastatic disease for PDAC with a specific focus on surgical resection for isolated hepatic and pulmonary metastases.

AB - The incidence of pancreatic adenocarcinoma (PDAC) has steadily increased over the past several decades. The majority of PDAC patients will present with distant metastases, limiting surgical management in this population. Hepatectomy and pulmonary metastasectomy (PM) has been well established for colorectal cancer patients with isolated, resectable hepatic or pulmonary metastatic disease. Recent advancements in effective systemic therapy for PDAC have led to the selection of certain patients where metastectomy may be potentially indicated. However, the indication for resection of oligometastases in PDAC is not well defined. This review will discuss the current literature on the surgical management of metastatic disease for PDAC with a specific focus on surgical resection for isolated hepatic and pulmonary metastases.

KW - Hepatic metastasis

KW - Oligometastasis

KW - Pancreatic cancer (PC)

KW - Pulmonary metastasis

KW - Surgical management

UR - http://www.scopus.com/inward/record.url?scp=84940562523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940562523&partnerID=8YFLogxK

U2 - 10.3978/j.issn.1000-9604.2015.05.02

DO - 10.3978/j.issn.1000-9604.2015.05.02

M3 - Review article

C2 - 26361405

AN - SCOPUS:84940562523

VL - 27

SP - 358

EP - 367

JO - Chinese Journal of Cancer Research

JF - Chinese Journal of Cancer Research

SN - 1000-9604

IS - 4

ER -